Circulating CD22+/CD19-/CD24- progenitors and CD22+/CD19+/CD24- mature B cells: Diagnostic pitfalls for minimal residual disease detection in B-lymphoblastic leukemia.
Ting ZhouJeremiah KarrsTruc HoAlyssa DoverteJames N KochenderferNirali N ShahConstance M YuanHao-Wei WangPublished in: Cytometry. Part B, Clinical cytometry (2022)
Our findings aid in building a complete immunophenotypic profile of normal cell populations in PB, thereby preventing misdiagnosis of B-ALL MRD and inappropriate management.